One of these seven patients (patient 20 in Table 2) had a concurrent rectal adenocarcinoma, and the EMPD in this patient likely represented secondary EMPD (CK7+, CK20+, CDX2−). The gene discussed is CDX2; the disease is rectum adenocarcinoma.